April 17, 2025
233 Sodium-glucose cotransporter-2 (SGLT2) inhibitors are commonly used for type 2 diabetes treatment, and in recent years, SGLT2 inhibitors canagliflozin has been shown to suppress IL-6 and IL-1 levels and MPO enzyme activity in the colon of UC rats by downregulating the expression of NF-B p65, thereby reducing colonic inflammatory cell infiltration and oxidative stress
A Semaglutide GLP-1 weight loss program typically lasts several months to over a year, depending on a persons goals, how their body responds, and medical supervision
Cooney MT, Vartiainen E, Laatikainen T et al (2010) Elevated resting heart rate is an independent risk factor for cardiovascular disease in healthy men and women
Life Extension
BCVA Best Corrected Visual Acuity, BMI Body Mass Index, Cog Cognition, H Headache, ICP Intracranial Pressure IIH Idiopathic Intracranial Hypertension, M/S Medication use or Surgical escalation, mo month(s) OCT Optical Coherence Tomography, OR Odds Ratio, RCT Randomized Controlled Trial, RR Risk Ratio, V Visual function/Papilledema, W Weight/Body Mass Index, wk week(s) The studied GLP-1 RAs included exenatide [14, 35, 37, 39], liraglutide [27, 3639], semaglutide [27, 34, 3739], lixisenatide [37, 39], dulaglutide [37, 39], albiglutide [39] and the dual agonist (GLP-1 and Glucose-dependent insulinotropic polypeptide (GIP)) tirzepatide [29, 37]